BeiGene, SpringWorks partner to assess targeted combination therapy in advanced solid tumors

Image: BeiGene, SpringWorks to evaluate lifirafenib, PD-0325901 combination in a phase 1b trial in advanced solid tumors. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.